Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.99% is 47% below its 5-year average of 1.89%, near the low end of its 5-year range (0.99%–2.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.56% below its 12-month average of 1.23%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.99%.
DEBT TO ASSETS RATIO
0.99%
DEBT TO ASSETS RATIO AVG TTM
1.23%
DEBT TO ASSETS RATIO AVG 3Y
1.82%
DEBT TO ASSETS RATIO AVG 5Y
1.89%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-19.56%
CURRENT VS 3Y AVG
-45.48%
CURRENT VS 5Y AVG
-47.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+1003.16%
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.81B
Debt to Assets Ratio
0.99%
TTM Avg
1.23%
3Y Avg
1.82%
5Y Avg
1.89%
Market Cap
$5.89B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.94B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.50B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.20B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.81B | 0.99% | 1.23% | 1.82% | 1.89% |
| Kodiak Sciences Inc. (KOD)vs › | $5.81B | 0.37% | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.89B | 0.05% | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.94B | 0.52% | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.64B | 0.01% | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $6.00B | 0.03% | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | 0.52% | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.50B | 0.01% | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.20B | 0.01% | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 0.21% | N/A | N/A | N/A |
Debt/Assets
1.0%
Debt/Equity
0.01
Current Ratio
3.90
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.99% |
| 2026-03-31 | 1.09% |
| 2025-12-31 | 1.24% |
| 2025-09-30 | 1.36% |
| 2025-06-30 | 1.48% |
| 2025-03-31 | 1.65% |
| 2024-12-31 | 1.70% |
| 2024-09-30 | 1.91% |
| 2024-06-30 | 2.10% |
| 2024-03-31 | 2.34% |
| 2023-12-31 | 2.33% |
| 2023-09-30 | 2.68% |
| 2023-06-30 | 2.79% |
| 2023-03-31 | 1.27% |
| 2022-12-31 | 1.29% |
| 2022-09-30 | 1.46% |
| 2022-06-30 | 2.19% |
| 2022-03-31 | 2.34% |
| 2021-12-31 | 2.60% |
| 2021-09-30 | 2.67% |
| 2021-06-30 | 2.20% |
| 2021-03-31 | 2.11% |
| 2020-12-31 | 2.00% |
| 2020-09-30 | 0.40% |
| 2020-06-30 | 0.67% |
| 2020-03-31 | 0.99% |
| 2019-12-31 | 1.04% |
| 2019-09-30 | 1.06% |
| 2019-06-30 | 1.08% |
| 2019-03-31 | 1.05% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
